Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway
Article in International Immunopharmacology (June 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (June 2024)
Article in Journal of Autoimmunity (May 2024)
Article in Pneumo News (December 2023)